Target intelligence / Profile preview

RNA, 7SK small nuclear pseudogene 126 (RN7SKP126)

Target: RN7SKP126
Molecular classification: Other (non-coding RNA pseudogene), Pseudogene

Overview

RN7SK pseudogene 126 (RN7SKP126) is a **non-coding RNA pseudogene** derived from the RN7SK gene, which encodes the 7SK small nuclear RNA. Unlike its functional counterpart, RN7SKP126 does not produce a functional RNA and has no established biological role. Pseudogenes of RN7SK result from genomic duplications or retrotransposition and do not participate in the formation of the 7SK small nuclear ribonucleoprotein (snRNP) complex, which is critical in regulating transcription elongation by RNA polymerase II via interaction with positive transcription elongation factor P-TEFb[4][1][2]. RN7SKP126 is classified within the family of non-coding RNA pseudogenes and bears no direct role in disease or as a drug target.

Other names: RN7SKP126RNA, 7SK small nuclear pseudogene 1267SK pseudogene 126

Mechanism of action

Not applicable — the target is a pseudogene, with no known mechanism of action or drug-targetable activity.

Biological functions

None documented for the pseudogene. Its functional parent gene, RN7SK, negatively regulates transcription elongation by RNA polymerase II and is part of the 7SK snRNP complex[4][1][2].

Disease associations

None directly associated with RN7SKP126. No disease-modifying roles or known associations; functional RN7SK is studied in transcriptional regulation and is implicated in processes relevant to HIV infection and transcriptional control but not the pseudogene[2][1].

Safety considerations

None specific; as a pseudogene, it does not present therapeutic safety issues, nor does it have challenges relevant to therapy development.

Interacting drugs

None documented — no drugs interact with RN7SKP126; drugs would interact with proteins or RNAs with biological function.

Biomarkers

None documented for RN7SKP126; not used as a biomarker for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on RNA, 7SK small nuclear pseudogene 126 (RN7SKP126).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 126 (RN7SKP126).

Explore the full profile